Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

RDNT vs DBVT vs ALKS vs SMID vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RDNT
RadNet, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.45B
5Y Perf.+237.4%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
SMID
Smith-Midland Corporation

Construction Materials

Basic MaterialsNASDAQ • US
Market Cap$186M
5Y Perf.+629.6%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

RDNT vs DBVT vs ALKS vs SMID vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RDNT logoRDNT
DBVT logoDBVT
ALKS logoALKS
SMID logoSMID
PRGO logoPRGO
IndustryMedical - Diagnostics & ResearchBiotechnologyBiotechnologyConstruction MaterialsDrug Manufacturers - Specialty & Generic
Market Cap$4.45B$1712.35T$5.90B$186M$1.61B
Revenue (TTM)$2.04B$0.00$1.56B$89M$4.18B
Net Income (TTM)$47M$-168M$153M$12M$-1.82B
Gross Margin11.2%65.4%28.0%34.2%
Operating Margin3.0%12.3%17.6%-4.1%
Forward P/E91.8x24.8x24.2x5.6x
Total Debt$1.86B$22M$70M$5M$3.97B
Cash & Equiv.$767M$194M$1.12B$8M$532M

RDNT vs DBVT vs ALKS vs SMID vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RDNT
DBVT
ALKS
SMID
PRGO
StockMay 20May 26Return
RadNet, Inc. (RDNT)100337.4+237.4%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Smith-Midland Corpo… (SMID)100729.6+629.6%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: RDNT vs DBVT vs ALKS vs SMID vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SMID leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. DBVT and ALKS also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
RDNT
RadNet, Inc.
The Healthcare Pick

Among these 5 stocks, RDNT doesn't own a clear edge in any measured category.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • Beta 1.06 vs SMID's 1.58, lower leverage
Best for: sleep-well-at-night and defensive
SMID
Smith-Midland Corporation
The Growth Play

SMID carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 31.8%, EPS growth 8.7%, 3Y rev CAGR 15.7%
  • 14.4% 10Y total return vs RDNT's 9.5%
  • 31.8% revenue growth vs DBVT's -100.0%
  • 13.2% margin vs PRGO's -43.5%
Best for: growth exposure and long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Lower P/E (5.6x vs 24.2x)
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthSMID logoSMID31.8% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 24.2x)
Quality / MarginsSMID logoSMID13.2% margin vs PRGO's -43.5%
Stability / SafetyALKS logoALKSBeta 1.06 vs SMID's 1.58, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)SMID logoSMID13.8% ROA vs DBVT's -89.0%

RDNT vs DBVT vs ALKS vs SMID vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RDNTRadNet, Inc.
FY 2025
Commercial Insurance1
58.8%$1.1B
Medicare1
24.8%$477M
Capitation Arrangements
6.5%$126M
Health Care, Other
3.4%$65M
Medicaid1
2.7%$52M
Workers' Compensation/Personal Injury1
2.3%$45M
Health Care, Management Service
1.4%$28M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
SMIDSmith-Midland Corporation
FY 2020
Shipping and Installation Revenue
100.0%$9M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

RDNT vs DBVT vs ALKS vs SMID vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. SMID is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$2.0B$0$1.6B$89M$4.2B
EBITDAEarnings before interest/tax$214M-$112M$212M$18M$58M
Net IncomeAfter-tax profit$47M-$168M$153M$12M-$1.8B
Free Cash FlowCash after capex-$178M-$151M$392M$5M$108M
Gross MarginGross profit ÷ Revenue+11.2%+65.4%+28.0%+34.2%
Operating MarginEBIT ÷ Revenue+3.0%+12.3%+17.6%-4.1%
Net MarginNet income ÷ Revenue+2.3%+9.8%+13.2%-43.5%
FCF MarginFCF ÷ Revenue-8.7%+25.1%+5.7%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+14.8%+28.2%-9.0%-7.2%
EPS Growth (YoY)Latest quarter vs prior year-114.1%+91.5%-4.1%-8.5%-56.4%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 5 of 6 comparable metrics.

At 24.2x trailing earnings, SMID trades at a 2% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than RDNT's 25.9x.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
Market CapShares × price$4.5B$1712.35T$5.9B$186M$1.6B
Enterprise ValueMkt cap + debt − cash$5.5B$1712.35T$4.9B$183M$5.1B
Trailing P/EPrice ÷ TTM EPS-230.00x-0.76x24.76x24.15x-1.14x
Forward P/EPrice ÷ next-FY EPS est.91.75x5.56x
PEG RatioP/E ÷ EPS growth rate0.79x
EV / EBITDAEnterprise value multiple25.88x17.25x14.60x7.42x
Price / SalesMarket cap ÷ Revenue2.18x4.00x2.37x0.38x
Price / BookPrice ÷ Book value/share3.19x0.66x3.28x4.45x0.55x
Price / FCFMarket cap ÷ FCF52.01x12.28x11.12x
PRGO leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

SMID leads this category, winning 7 of 9 comparable metrics.

SMID delivers a 22.6% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to RDNT's 1.37x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+3.8%-130.2%+8.8%+22.6%-50.7%
ROA (TTM)Return on assets+1.3%-89.0%+5.4%+13.8%-19.8%
ROICReturn on invested capital+2.0%+18.9%+21.2%+3.7%
ROCEReturn on capital employed+2.1%-145.7%+14.2%+20.1%+4.3%
Piotroski ScoreFundamental quality 0–954774
Debt / EquityFinancial leverage1.37x0.13x0.04x0.12x1.35x
Net DebtTotal debt minus cash$1.1B-$172M-$1.0B-$2M$3.4B
Cash & Equiv.Liquid assets$767M$194M$1.1B$8M$532M
Total DebtShort + long-term debt$1.9B$22M$70M$5M$4.0B
Interest CoverageEBIT ÷ Interest expense1.46x-189.82x32.30x72.70x-7.20x
SMID leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SMID leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in SMID five years ago would be worth $26,938 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors SMID at 29.0% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-19.0%+4.9%+25.3%-6.6%-13.5%
1-Year ReturnPast 12 months+4.6%+110.4%+16.5%+14.2%-51.2%
3-Year ReturnCumulative with dividends+100.0%+19.7%+14.5%+114.7%-58.1%
5-Year ReturnCumulative with dividends+147.1%-69.1%+60.9%+169.4%-60.1%
10-Year ReturnCumulative with dividends+947.4%-87.0%-11.0%+1436.8%-77.7%
CAGR (3Y)Annualised 3-year return+26.0%+6.2%+4.6%+29.0%-25.2%
SMID leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than SMID's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.43x1.26x1.06x1.58x1.18x
52-Week HighHighest price in past year$85.84$26.18$36.60$43.66$28.44
52-Week LowLowest price in past year$50.76$7.53$25.17$25.56$9.23
% of 52W HighCurrent price vs 52-week peak+67.0%+76.3%+96.7%+80.2%+41.2%
RSI (14)Momentum oscillator 0–10051.348.160.258.160.9
Avg Volume (50D)Average daily shares traded822K252K2.3M9K3.4M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: RDNT as "Buy", DBVT as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricRDNT logoRDNTRadNet, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSMID logoSMIDSmith-Midland Cor…PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$92.00$46.33$44.00$20.00
# AnalystsCovering analysts11152836
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises000010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

RDNT vs DBVT vs ALKS vs SMID vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is RDNT or DBVT or ALKS or SMID or PRGO a better buy right now?

For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.

8% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Smith-Midland Corporation (SMID) offers the better valuation at 24. 2x trailing P/E, making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RDNT or DBVT or ALKS or SMID or PRGO?

On trailing P/E, Smith-Midland Corporation (SMID) is the cheapest at 24.

2x versus Alkermes plc at 24. 8x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — RDNT or DBVT or ALKS or SMID or PRGO?

Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +169.

4%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: SMID returned +1437% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RDNT or DBVT or ALKS or SMID or PRGO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus Smith-Midland Corporation's 1. 58β — meaning SMID is approximately 49% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — RDNT or DBVT or ALKS or SMID or PRGO?

By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.

8% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RDNT or DBVT or ALKS or SMID or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RDNT or DBVT or ALKS or SMID or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 91. 8x for RadNet, Inc. — 86. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — RDNT or DBVT or ALKS or SMID or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. RDNT, DBVT, ALKS, SMID do not pay a meaningful dividend and should not be held primarily for income.

09

Is RDNT or DBVT or ALKS or SMID or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Smith-Midland Corporation (SMID) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1437% 10Y return).

Both have compounded well over 10 years (SMID: +1437%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RDNT and DBVT and ALKS and SMID and PRGO?

These companies operate in different sectors (RDNT (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and SMID (Basic Materials) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RDNT is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; SMID is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while RDNT, DBVT, ALKS, SMID do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

RDNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

SMID

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.